LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 2 of total 2

Search options

  1. Article: Leishmanicidal activity of Morita-Baylis–Hillman adducts

    Vieira, Ana Carolina Santana / da Silva Santos, Mariana / Leite, Anderson Brandão / da Silva, Amanda Evelyn / Cavalcante-Silva, Luiz Henrique Agra / de Souza Augusto Pereira, Gabrielle / Marques, Sany Delany Gomes / de Oliveira Santos, Barbara Viviana / Duarte, Alysson Wagner Fernandes / de Queiroz, Aline Cavalcante / de Luna-Freire, Kristerson Reinaldo / Alexandre-Moreira, Magna Suzana

    Parasitology research. 2022 Feb., v. 121, no. 2

    2022  

    Abstract: Leishmaniasis is a neglected disease that affects millions of people, mostly in developing countries. Although this disease has a high impact on public health, there are few drug options to treat the different leishmaniasis forms. Additionally, these ... ...

    Abstract Leishmaniasis is a neglected disease that affects millions of people, mostly in developing countries. Although this disease has a high impact on public health, there are few drug options to treat the different leishmaniasis forms. Additionally, these current therapies have various adverse effects, including gastrointestinal disturbances, headache, pancreatitis, and hepatotoxicity. Thus, it is essential to develop new drug prototypes to treat leishmaniasis. Accordingly, the present study aimed to evaluate the leishmanicidal activity of Morita-Baylis–Hillman adducts and their O-acetylates, carboxylic acid derivatives, and acid and ester derivatives of 2-methyl-phenylpropanoids against Leishmania chagasi. Initially, we evaluated the cytotoxicity of 16 derivatives (1-16G) against J774A.1 macrophages. Eight derivatives (2G, 4G, 5G, 7G, 9G, 10G, 13G, and 15G) showed no cytotoxicity at up to the maximum concentration tested (100 μM). When evaluated for antileishmanial effect against promastigote forms, 1G, 6G, 8G, 10G, 11G, 13G, 14G, 15G, and 16G displayed significant toxicity compared to the control (0.1% DMSO). Additionally, the compounds 1G, 5G, 7G, 9G, 11G, 13G, 14G, and 16G reduced macrophage infection by amastigotes. Thus, we conclude that these derivatives have antileishmanial effects, particularly 1G, which showed activity against promastigotes and amastigotes, and low toxicity against macrophages.
    Keywords Leishmania donovani ; amastigotes ; antileishmanial properties ; carboxylic acids ; cytotoxicity ; drugs ; gastrointestinal system ; headache ; hepatotoxicity ; leishmaniasis ; macrophages ; pancreatitis ; parasitology ; promastigotes ; public health
    Language English
    Dates of publication 2022-02
    Size p. 751-762.
    Publishing place Springer Berlin Heidelberg
    Document type Article
    ZDB-ID 284966-5
    ISSN 1432-1955 ; 0932-0113 ; 0044-3255
    ISSN (online) 1432-1955
    ISSN 0932-0113 ; 0044-3255
    DOI 10.1007/s00436-021-07421-3
    Database NAL-Catalogue (AGRICOLA)

    More links

    Kategorien

  2. Article ; Online: Leishmanicidal activity of Morita-Baylis-Hillman adducts.

    Vieira, Ana Carolina Santana / da Silva Santos, Mariana / Leite, Anderson Brandão / da Silva, Amanda Evelyn / Cavalcante-Silva, Luiz Henrique Agra / de Souza Augusto Pereira, Gabrielle / Marques, Sany Delany Gomes / de Oliveira Santos, Barbara Viviana / Duarte, Alysson Wagner Fernandes / de Queiroz, Aline Cavalcante / de Luna-Freire, Kristerson Reinaldo / Alexandre-Moreira, Magna Suzana

    Parasitology research

    2022  Volume 121, Issue 2, Page(s) 751–762

    Abstract: Leishmaniasis is a neglected disease that affects millions of people, mostly in developing countries. Although this disease has a high impact on public health, there are few drug options to treat the different leishmaniasis forms. Additionally, these ... ...

    Abstract Leishmaniasis is a neglected disease that affects millions of people, mostly in developing countries. Although this disease has a high impact on public health, there are few drug options to treat the different leishmaniasis forms. Additionally, these current therapies have various adverse effects, including gastrointestinal disturbances, headache, pancreatitis, and hepatotoxicity. Thus, it is essential to develop new drug prototypes to treat leishmaniasis. Accordingly, the present study aimed to evaluate the leishmanicidal activity of Morita-Baylis-Hillman adducts and their O-acetylates, carboxylic acid derivatives, and acid and ester derivatives of 2-methyl-phenylpropanoids against Leishmania chagasi. Initially, we evaluated the cytotoxicity of 16 derivatives (1-16G) against J774A.1 macrophages. Eight derivatives (2G, 4G, 5G, 7G, 9G, 10G, 13G, and 15G) showed no cytotoxicity at up to the maximum concentration tested (100 μM). When evaluated for antileishmanial effect against promastigote forms, 1G, 6G, 8G, 10G, 11G, 13G, 14G, 15G, and 16G displayed significant toxicity compared to the control (0.1% DMSO). Additionally, the compounds 1G, 5G, 7G, 9G, 11G, 13G, 14G, and 16G reduced macrophage infection by amastigotes. Thus, we conclude that these derivatives have antileishmanial effects, particularly 1G, which showed activity against promastigotes and amastigotes, and low toxicity against macrophages.
    MeSH term(s) Antiprotozoal Agents/toxicity ; Humans ; Leishmaniasis/drug therapy ; Macrophages ; Organic Chemicals
    Chemical Substances Antiprotozoal Agents ; Organic Chemicals
    Language English
    Publishing date 2022-01-06
    Publishing country Germany
    Document type Journal Article
    ZDB-ID 284966-5
    ISSN 1432-1955 ; 0932-0113 ; 0044-3255
    ISSN (online) 1432-1955
    ISSN 0932-0113 ; 0044-3255
    DOI 10.1007/s00436-021-07421-3
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top